Article Information
PubMed
Published By
History
- Received November 18, 2014
- Revision received January 7, 2015
- Accepted January 14, 2015
- Published online January 16, 2015.
Copyright & Usage
Copyright © 2014 Wright et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- 1The Baker Laboratory of Pharmacology, Department of Pharmacology, Kirksville College of Osteopathic Medicine, at Still University of Health Sciences, Kirksville, Missouri 63501
- 2 Department of Physiology, Kirksville College of Osteopathic Medicine, at Still University of Health Sciences, Kirksville, Missouri 63501
- 3 George E. Wahlen Veterans Affairs Medical Center and Departments of Psychiatry and Biology, University of Utah, Salt Lake City, Utah 84148
- Correspondence should be addressed to Keith S. Elmslie, Department of Pharmacology, AT Still University of Health Sciences, Kirskville College of Osteopathic Medicine, 800 W. Jefferson Street, Kirksville, MO 63501. E-mail: kelmslie{at}atsu.edu.
Author contributions
↵2 Author contributions: A.B.W., Y.N., J.M.M., and K.S.E. designed research; A.B.W., Y.N., and K.S.E. performed research; J.M.M. contributed unpublished reagents/analytic tools; A.B.W., Y.N., and K.S.E. analyzed data; A.B.W., Y.N., J.M.M., and K.S.E. wrote the paper.
Disclosures
↵1 The authors declare no competing financial interests.
↵3 The funding for this work came from NIH Grants GM48677, GM103801 (J.M.M.), and AR59397 (K.S.E.). The University of Utah holds patents on α-conotoxin RgIA, of which J. Michael McIntosh is listed as an inventor. We thank Doju Yoshikami for critical reading of the manuscript.
Funding
NIH NIGMS
GM48677NIH NIGMS
GM103801NIH NIAMS
AR59397
Other Version
- You are viewing the most recent version of this article.
- previous version (January 16, 2015).
- previous version (January 16, 2015).
Online Impact
Article usage
In this issue
Limited Efficacy of α-Conopeptides, Vc1.1 and RgIA, To Inhibit Sensory Neuron CaV Current
